Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Moxidectin
Norbrook Laboratories (Ireland) Limited
QP54AB02
Moxidectin
5 milligram(s)/millilitre
Pour-on solution
POM: Prescription Only Medicine as defined in relevant national legislation
moxidectin
Authorised
2017-03-01
Page 1 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tauramox 5 mg/ml Pour-On Solution for Cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Moxidectin 5 mg EXCIPIENT(S): Tertiary Butylhydroquinone (E319) 0.03 mg Butylhydroxyanisole (E320) 0.1 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Pour-on Solution A translucent, colourless to pale yellow slightly viscous solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Infections of cattle with parasites sensitive to moxidectin. For the treatment of infections caused by: - ADULT AND LARVAL GASTRO-INTESTINAL NEMATODES: _Haemonchus placei_ _Ostertagia ostertagi _ (including inhibited larvae) _Trichostrongylus axei_ _Nematodirus helvetianus_ _Cooperia oncophora_ _Cooperia punctata _ (adults) _Oesophagostomum radiatum _ (adults) _Bunostomum phlebotomum _ (adults) - ADULT RESPIRATORY TRACT NEMATODE _Dictyocaulus viviparus _ _ _ _ _- WARBLES (MIGRATING LARVAE) _Hypoderma bovis_ _Hypoderma lineatum_ - LICE _Linognathus vituli_ _Haematopinus eurysternus_ Page 2 of 7 _Solenopotes capillatus_ _Bovicola bovis (Damalinia bovis)_ - MANGE MITES _Sarcoptes scabiei_ _Psoroptes ovis_ _Chorioptes bovis_ - HORN FLIES _Haematobia irritans_ THE PRODUCT HAS A PERSISTENT EFFECT IN PREVENTING AGAINST REINFECTION BY: _Ostertagia ostertagi _ for 5 weeks _Dictyocaulus viviparus _ for 6 weeks. 4.3 CONTRAINDICATIONS Do not use in other species as severe adverse reactions, including fatalities in dogs, may occur. Do not use in cases of hypersensitivity to the active substance or any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES For cutaneous application only. Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - under dosing, which may be Belgenin tamamını okuyun